Standout Papers

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metas... 2011 2026 2016 2021 853
  1. Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma (2011)
    David H. Henry, Luís Costa et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 75 standout
Sub-graph 1 of 20

Citing Papers

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
2022 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
12 intermediate papers

Works of H.P. Sleeboom being referenced

Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial
2011
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride
1987
and 3 more

Author Peers

Author Last Decade Papers Cites
H.P. Sleeboom 1513 477 325 530 21 1.8k
María Eugenia Ibarrarán Viniegra 1423 414 340 516 17 1.6k
Justus Apffelstaedt 1623 621 550 464 41 2.1k
Michael Rader 1788 654 411 447 18 2.3k
Jean-Jacques Body 2244 697 542 749 24 2.7k
Lester Porter 1745 620 363 439 10 2.1k
M.N.C. Benéton 1441 276 305 1098 46 2.2k
Ian Kennedy 1673 616 389 245 20 2.2k
Richard H. De Boer 1652 358 285 409 47 2.0k
Julie C. Frith 2253 645 309 1131 17 2.9k
Ada Braun 2605 732 637 801 62 3.1k

All Works

Loading papers...

Rankless by CCL
2026